2y amenorrhoea and menopause Flashcards
(43 cards)
what is menopause
a woman’s last ever period
~51y/o
1/3 of UK lifespan after menopause
perimenopause 3-5yrs before final period, can have menopausal symptoms during this
what is premature menopause
<40y/o
affects 1% women
what happens at menopause - hormones
ovarian insufficiency - oestradiol falls
FSH from pituitary rises
still some oestriol from conversion of adrenal androgens in adipose tissue
FSH levels in perimenopause
levels fluctuate
one off level doesn’t exclude perimenopause as a cause for symptoms
how does menopausal transition occur
may be natural or sudden following oophorectomy/chemotherapy/radiotherapy
menopause symptoms
vasomotor - hot flushes/night sweats, 80% women affected, 45% significant problem, usually last 2-5yrs, may be >10yrs
vaginal dryness/soreness
low libido
muscle and joint aches
mood changes/poor memory - possibly related to vasomotor symptoms affecting sleep
osteoporosis in menopause
reduced oestrogen - lowered BMD
what is osteoporosis
reduced bone mineral density
tested for w/ DEXA scan - T score
problems with osteoporosis following menopause
fractured hip/vertebrae
1% women 50-69
significant morbidity and mortality
osteoporosis risk factors
thin caucasian smoker high alcohol intake (EtOH) \+ve FHx esp male or younger age malabsorption vit D and Ca prolonged low oestrogen before menopause and amenorrhoea oral corticosteroids hyperthyroid
prevention and treatment of osteoporosis
wight bearing exercise adequate Ca and vit D HRT bisphosphonates denosumab - monoclonal ab to osteoclasts calcitonin
HRT for menopausal symptoms
- local vaginal HRT - oestrogen pessary/ring/cream - minimal systemic absorption, need to use longterm to maintain benefit
- systemic oestrogen transdermal patch/gel or oral - transdermal avoids 1st pass + less risk VTE
oestrogen only if no uterus
oestrogen and progesterone is uterus present - progestogen oral, patch or LNG IUS
why can oestrogen alone not be used if the woman still has a uterus
risk of endometrial hyperplasia and endometrial cancer
progesterone has to also be used for protection against this
combined oestrogen and progestogen HRT - women with ovarian function
for women who still have some ovarian function to avoid inconvenience of irregular bleeding
cyclical combined HRT - 14 days E, 14 days E+P
expect withdrawal bleed after P
combined oestrogen and progestogen HRT - women w/o any likely natural ovarian function
continuous combined 28 days E+P oral/patch
expect to be bleed free after 1st 3mths
use if >1yr after LMP or age >54
what combined oestrogen and progestogen HRT can be used for women of any age
Mirena LNG IUS 5yrs + daily E
expect to be bleed free
what HRT regime gives contraceptive cover
mirena + E
CI to systemic HRT
not the same as CI to combined hormonal contraception
- current hormone dependent breast/endometrium cancer
- current active liver disease
- uninvestigated abnormal vaginal bleeding
- seek advice if prev VTE, thrombophilia, FH VTE
- seek advice if prev breast cancer or BRCA carrier
CI to vaginal HRT
avoid for women taking aromatase inhibitor treatment for breast cancer - but may choose to use if symptoms affecting QOL
no other CI as minimal systemic absorption
treatment for symptoms of menopause
HRT
SERMs
clonidine/SSRI/SNRI antidepressants
phytooestrogen herbs e.g. red clover, soya
hypnotherapy/exercise/CBT
non-hormonal lubricants for vaginal dryness
SERMs
selective oestrogen receptor modulators
E effect on selected organs
e.g. tibolone has E effect on flushes, bones but not endometrium
clonidine or SSRI SNRI antidepressants
e.g. venlafaxine
NOT recommended for vasomotor symptoms
frequent side effects and few women benefit
HRT benefits
vasomotor
local genital symptoms
osteoporosis
no effect on alzheimers
no increase in CV risks if start before 60y/o (before significant atherosclerosis develops)
risks of HRT
breast Ca if combined HRT
ovarian Ca
VTE if oral route
CVA if oral route